肺活量
- vital capacity;lung's capacity;pulmonary
-
[vital capacity] 肺呼吸容量,在吸足后尽力呼出的空气量,以升或立方厘米数量来表示
-
中年男性用力肺活量正常参考值的地理分布规律卡维地洛对正常青年男性P波间期离散度的影响
The geographical distribution of the normal reference value of forced vital capacity of middle-aged men The influence of carvedilol on Pd of young men in good health
-
平均肺活量,最大摄氧量及其相对值等数据均较实验前相比差异性也很大。(p值分别0.05)。
The average vital capacity , maximum oxygen uptake and its relative value compared to other data than those before the experiment significant differences ( p values 0.05 ) .
-
式中Y为肺活量(ml),X为屏气时间(s)。
Y represents the VC ( ml ) and X represents the BHT ( s ) .
-
A、B组治疗中期及治疗后用力肺活量(FVC)显著增加。
The FVC increased markedly in A and B group at the middle and end of treatment .
-
COPD患者和健康人呼吸氦氧混合气后肺活量变化的比较(英文)
Comparison in change in vital capacity of COPD patients and normal subjects after breathing helium-oxygen mixture ( heliox )
-
经24h无创正压通气治疗后,患者的动脉血气指标、肺活量和肺不张情况均较对照组明显改善(P<005),无创正压通气对术后疼痛有一定的缓解作用(P<005)。
Arterial blood gas parameters and vital capacity in NIPPV group were better than those in control group .
-
呼吸机能中肺活量和心率的实验前后的数据对比均是p0.01,都有显著性的变化。
Respiratory function in the lungs and heart rate compared before and after the experiment data are p 0.01 , have significant changes .
-
吸烟对体质指标中的机能指标影响明显,尤其肺活量,t检验(P0.05)差异具有显著性。
Of smoking on physical indicators of the functional indicators of significant impact , particularly in vital capacity , t test ( P 0.05 ) difference was significant .
-
COPD患者骨密度与用力肺活量(FVC%)、一秒钟用力呼气量(FEV1%)及一秒率(FEV1/FVC%)均呈显著正相关(P<0.05)。
BMD in COPD patients was positively correlated with FVC % , FEV1 % and FEV1 / FVC % ( P < 0.05 ) .
-
而肺活量指数明显低于正常组(P0.001)。
And the VC index is obviously lower than the normal group ( P0.001 ) . 2 .
-
2010年的舒张压、肺活量、肺活量体重指数要明显高于2005年,差异非常显著(p0.01)。
2010 diastolic blood pressure , vital capacity , vital capacity body-mass index significantly faster than in 2005 , difference is very significant ( p 0.01 ) .
-
治疗组治疗后肺活量、免疫球蛋白、CO2结合力、血氧都有明显改善(P<0.01,P<0.05)
Vital capacity , immunoglobulin , CO 2-combining power and blood oxygen content significantly improved after treatment in the treatment group ( P < 0.01 , P < 0.05 ) .
-
用力肺活量作为分析的参数使用混合的模型反复使用ANOVA和配对t检验进行统计学比较。
Percent forced vital capacity was the outcome parameter with data analysis using a mixed-model repeated-measures ANOVA and paired t tests .
-
最大肺活量(FVC)是诊所ALS患者存活和病情进展的预测因素
Forced vital capacity ( FVC ) as an indicator of survival and disease progression in an ALS clinic population
-
目的探讨缓解期慢性阻塞性肺疾病(COPD)患者呼吸氦氧混合气(HeO2)后肺活量(VC)及其组成的变化。
Objective To investigate the change of vital capacity and its components after breathing helium-oxygen mixture ( He-O 2 ) in stable patients with chronic obstructive pulmonary disease ( COPD ) .
-
B组9例术后膈神经修复侧膈肌均麻痹不动,肺活量及最大呼吸容量为术前的72%~84%及76%~84%;
And in group B , ipsilateral diaphragm paralysis in 9 cases after surgery , whose vital capacity and forced vital capacity had decreased to 72 % - 84 % , 76 % - 84 % of that before the surgery respectively ;
-
与缓解组第1秒用力呼气流量(FEV1)、50%肺活量时最大呼气流量(FEF50)比较,轻度哮喘组无统计学意义(P0.05);
There was no difference in FEV 1 , FEF 50 between slight asthma group and remission group ;
-
结果CTD组肺功能检测弥散功能明显受损(P<0.01)、肺活量减损。
Results The function of diffusion of lung and the vital capacity of 27 cases with CTD were lower than control group .
-
动脉血氧分压指标下降,1秒钟用力呼气容积占用力肺活量百分比(FEV1/FVC)指标上升,但差值比较无统计学意义(P>0.05)。
PaO2 declined and FEV1 / FVC rised , the differences were not significant ( P > 0.05 ) .
-
骨折组内俯卧位组的肺活量和FEV1明显低于坐位组及侧卧位组。
VC and FEV1 in prone position were obviously lower than those in sitting position and lateral decubitus position in fracture group .
-
本文运用Logistic回归分析、直线回归分析、相关分析、聚类分析和因子分析,对肺活量、血压和脉搏等项身体机能指标进行了筛选,提出了评价身体机能的新方案。
We applied Logistic regression , linear regression , correlation analysis , cluster analysis ami factor analysis to sieve somatic function indexes , and put forward a new schewe which form an estimate of student individual somatic function .
-
结果:呼吸氦氧混合气后,肺活量较呼吸空气时增加了19.2%(P0.05),补呼气容积增加了87.3%(P0.05),深吸气量减低了7.39(P0.05)。
Result : After breathing helium-oxygen mixture , vital capacity increased 19.2 % compared with breathing air ( P0.05 ), and expiratory capacity increased 87.3 % ( P0.05 ), while inspiratory capacity decreased 7.39 % ( P0.05 ) .
-
同时采用F-Ⅱ型肺量计做安静时与练拳后5次肺活量试验(FVCT)。
While applying F -ⅱ Vital Capacity Gauge had tests of Five Vital Capcity ( FVCT ) In rest and after exercise .
-
武汉市选择BMI指数、肺活量/体重指数、握力/体重指数、立定跳远4项指标在中考体育考试中对学生的体质健康状况进行评价是科学的。
It is scientific for Wuhan City to choose BMI index , vital capactiy / weight index , grip / weight index to evaluate the physical and heathy conditions of students in high school entrance .
-
南拳上肢以及前臂肌肉较为发达,各种围度指标较高,腰围/臀围、BMI指数、克托莱、肺活量、肺活量/身高指数大。
Nanquan upper and forearm muscles are more developed , a variety of indicators of higher circumference , waist / hip circumference , BMI index , Quetelet , vital capacity , vital capacity / height indices .
-
同时患者进行常规肺功能测定,包括肺活量(VC)、单次呼吸法弥散功能(一氧化碳弥散量TLCOSB%),此外还有血气分析中的PA-aO2等数据的测定。
At the same time patients undergoing routine pulmonary function testing , including spirometry ( VC ), single breath diffusing capacity ( TLcosB % diffusion capacity for carbon monoxide ), and blood gas analysis in P ( A-a ) O2data determination .
-
肺活量和1000m(女800m)跑则非常显著的差于普通大学生,提示加强聋生体育锻炼的科学指导,增强聋生体质是重要的。
It indicated that scientific theory should be put into the deaf mute students ' physical exercises , and it was very important to improve their constitution .
-
肺功能检查结果。包括用力肺活量(FVC),第一秒时间肺活量(FEV1)和一秒率(FEV1/FVC)等。
Pulmonary function tests ( PFT ), including forced vital capacity ( FVC ), forced the first second of expiratory volume ( FEV1 ) and FEV1 / FVC .
-
目的了解肺癌患者肺功能最大呼吸流速容量曲线(MEFV)变化的意义及其变化与气道阻力(Raw)、用力肺活量(FVC)测定相关性。
Objective To explore pulmonary function maximal expiratory flow volume curve ( MEFV ) and relation between MEFV and airway resistance ( Raw ), forced vital capacity ( FVC ) with lung cancer .
-
功能类指标测试结果:实验后实验组肺活量大于对照组犤(2132±365),(2020±423)N犦,坐站试验安静心率;
Measure result of function index : The vital capacity of the people in the experimental group after trial was larger than that in the control group [ ( 2 132 ± 365 ),( 2 020 ± 423 ) N ] , the quiet cardiac rate in the sit-stand trial ;